Milestone says CARDAMYST restored normal heart rhythm in 66.7% vs 20.0% on placebo in Phase 3 post-ablation subgroup

Milestone Pharmaceuticals says CARDAMYST restored normal heart rhythm in 66.7% of patients vs 20.0% on placebo in a Phase 3 subgroup of 11 post-ablation patients.

Detected & updated continuously · Source: Nebula